ALLOVIR Trademark

Trademark Overview

On Thursday, April 11, 2019, a trademark application was filed for ALLOVIR with the United States Patent and Trademark Office. The USPTO has given the ALLOVIR trademark a serial number of 88381011. The federal status of this trademark filing is SU - NON-FINAL ACTION - MAILED as of Tuesday, May 28, 2024. This trademark is owned by ViraCyte Inc.. The ALLOVIR trademark is filed in the Pharmaceutical Products category with the following description:

Anti-cancer preparations; anti-infectives; biological preparations for the treatment of cancer and acute and chronic devastating diseases and conditions; biological preparations for the treatment of cancer; medical preparations for the treatment of cancer and acute and chronic devastating diseases and conditions; medicinal preparations for the treatment of infectious diseases and for use in oncology; mixed biological preparations for the prevention and treatment of infectious diseases; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of cancer and acute and chronic devastating diseases and conditions; pharmaceutical preparations for the prevention and treatment of diabetes, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical products for the prevention and ...
allovir

General Information

Serial Number88381011
Word MarkALLOVIR
Filing DateThursday, April 11, 2019
Status807 - SU - NON-FINAL ACTION - MAILED
Status DateTuesday, May 28, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 25, 2020

Trademark Statements

Goods and ServicesAnti-cancer preparations; anti-infectives; biological preparations for the treatment of cancer and acute and chronic devastating diseases and conditions; biological preparations for the treatment of cancer; medical preparations for the treatment of cancer and acute and chronic devastating diseases and conditions; medicinal preparations for the treatment of infectious diseases and for use in oncology; mixed biological preparations for the prevention and treatment of infectious diseases; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of cancer and acute and chronic devastating diseases and conditions; pharmaceutical preparations for the prevention and treatment of diabetes, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical products for the prevention and treatment of cancer; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; therapeutic pharmaceutical for the treatment of cancer and acute and chronic devastating diseases
Pseudo MarkALLOVER

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 29, 2019
Primary Code005
First Use Anywhere DateTuesday, October 31, 2023
First Use In Commerce DateTuesday, October 31, 2023

Trademark Owner History

Party NameALLOVIR, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressWaltham, MA 02451
Party NameViraCyte Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressHouston, TX 77098
Party NameViraCyte Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHouston, TX 77098

Trademark Events

Event DateEvent Description
Monday, April 15, 2019NEW APPLICATION ENTERED
Monday, April 29, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 21, 2019ASSIGNED TO EXAMINER
Saturday, June 22, 2019NON-FINAL ACTION WRITTEN
Saturday, June 22, 2019NON-FINAL ACTION E-MAILED
Saturday, June 22, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, January 3, 2020ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Friday, January 3, 2020ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Saturday, January 4, 2020TEAS PETITION TO REVIVE RECEIVED
Saturday, January 4, 2020PETITION TO REVIVE-GRANTED
Saturday, January 4, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, January 6, 2020NOTICE OF REVIVAL - E-MAILED
Friday, January 17, 2020ASSIGNED TO LIE
Friday, January 17, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 17, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, January 18, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 5, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 25, 2020PUBLISHED FOR OPPOSITION
Tuesday, February 25, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 21, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, May 27, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, October 21, 2020SOU EXTENSION 1 FILED
Monday, November 23, 2020TEAS PETITION TO REVIVE RECEIVED
Monday, November 23, 2020PETITION TO REVIVE-GRANTED
Monday, November 23, 2020SOU EXTENSION RECEIVED WITH TEAS PETITION
Monday, November 23, 2020ABANDONMENT - NO USE STATEMENT FILED
Monday, November 23, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Tuesday, November 24, 2020NOTICE OF REVIVAL - E-MAILED
Monday, February 22, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, February 23, 2021SOU EXTENSION 1 GRANTED
Wednesday, February 24, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 21, 2021SOU EXTENSION 2 FILED
Monday, May 24, 2021TEAS PETITION TO REVIVE RECEIVED
Monday, May 24, 2021PETITION TO REVIVE-GRANTED
Monday, May 24, 2021SOU EXTENSION RECEIVED WITH TEAS PETITION
Monday, May 24, 2021ABANDONMENT - NO USE STATEMENT FILED
Monday, May 24, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Tuesday, May 25, 2021NOTICE OF REVIVAL - E-MAILED
Friday, May 28, 2021SOU EXTENSION 2 GRANTED
Saturday, May 29, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 10, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, June 10, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, June 10, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 19, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, October 19, 2021SOU EXTENSION 3 FILED
Tuesday, October 19, 2021SOU EXTENSION 3 GRANTED
Thursday, October 21, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 21, 2022SOU TEAS EXTENSION RECEIVED
Thursday, April 21, 2022SOU EXTENSION 4 FILED
Thursday, April 21, 2022SOU EXTENSION 4 GRANTED
Saturday, April 23, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 20, 2022SOU TEAS EXTENSION RECEIVED
Thursday, October 20, 2022SOU EXTENSION 5 FILED
Tuesday, October 25, 2022SOU EXTENSION 5 GRANTED
Wednesday, October 26, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 23, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, March 23, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, March 23, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 23, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, March 23, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, April 18, 2023TEAS STATEMENT OF USE RECEIVED
Tuesday, April 18, 2023USE AMENDMENT FILED
Wednesday, April 26, 2023STATEMENT OF USE PROCESSING COMPLETE
Tuesday, May 30, 2023SU - NON-FINAL ACTION - WRITTEN
Tuesday, May 30, 2023NON-FINAL ACTION E-MAILED
Tuesday, May 30, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 6, 2023TEAS PETITION TO DIRECTOR RECEIVED
Monday, July 3, 2023ASSIGNED TO PETITION STAFF
Monday, July 17, 2023PETITION TO DIRECTOR GRANTED
Monday, July 31, 2023HIDDEN SENSITIVE CONTENT
Tuesday, August 29, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, August 29, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, November 7, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 25, 2024ASSIGNED TO LIE
Monday, March 25, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 25, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 22, 2024SU - NON-FINAL ACTION - WRITTEN
Tuesday, April 23, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, April 22, 2024NON-FINAL ACTION E-MAILED
Monday, April 22, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 24, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 24, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 28, 2024NON-FINAL ACTION E-MAILED
Tuesday, May 28, 2024SU - NON-FINAL ACTION - WRITTEN
Tuesday, May 28, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED

Related Keywords

allovir preparations treatment diseases pharmaceutical cancer infectious anti prevention conditions devastating